Coca-Cola earnings beat Wall Street estimates as revenue jumps 16%

Coca-Cola earnings beat Wall Street estimates as revenue jumps 16%


A person wearing a mask pushes a dolly cart past a Coca-Cola truck as the city continues Phase 4 of re-opening following restrictions imposed to slow the spread of coronavirus on September 16, 2020 in New York City.

Alexi Rosenfeld | Getty Images

Coca-Cola on Monday reported quarterly earnings that topped analysts’ expectations as consumers drank more of its trademark soda, Powerade and other beverages.

Shares of the company rose less than 1% in premarket trading.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: 64 cents adjusted vs. 58 cents expected
  • Revenue: $10.5 billion

Excluding items, the beverage giant earned 64 cents per share, beating the 58 cents per share expected by analysts surveyed by Refinitiv.

Net sales rose 16% to $10.5 billion.

This is breaking news. Please check back for updates.



Source

Stellantis scraps Jeep, Chrysler plug-in hybrid vehicles amid EV slowdown, recall
Business

Stellantis scraps Jeep, Chrysler plug-in hybrid vehicles amid EV slowdown, recall

The Camp Jeep outdoor terrain at the New York International Auto Shown on April 16, 2025. Danielle DeVries | CNBC DETROIT — Stellantis is scrapping its plug-in hybrid electric Jeep SUVs and Chrysler minivan amid slowing EV sales, quality issues and weakened federal fuel economy requirements. The automaker on Friday said the decision to end […]

Read More
Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill
Business

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Amazon announced Friday it now offers Novo Nordisk‘s Wegovy weight-loss pill through its digital pharmacy. Novo Nordisk began rolling out an oral version of its injectable obesity drug Wegovy in the […]

Read More
As tech stocks soar, executives use exchange funds to diversify wealth without selling
Business

As tech stocks soar, executives use exchange funds to diversify wealth without selling

Yuichiro Chino | Moment | Getty Images For executives and founders who have gotten rich off one stock, sometimes it is possible to have too much of a good thing. While the tech stock boom has meant a windfall for employees at high-flying companies, it’s risky to have too much of your net worth tied […]

Read More